BROOKS LABORATORIES LTD.
BSE: 533543
Revenue & Profit Trend
in croresMargin Trend
percentage| Period | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 22.96+13.6% | 20.21+22.0% | 16.57-29.4% | 23.45-8.1% | 25.51+9.4% | 23.32+13.7% | 20.52-1.3% | 20.79 |
| Other Income | 0.18-59.7% | 0.44+250.6% | 0.13-68.0% | 0.39+79.8% | 0.22-65.0% | 0.62+2116.4% | 0.03-85.9% | 0.20 |
| Total Income | 23.14+12.1% | 20.65+23.7% | 16.69-30.0% | 23.84-7.3% | 25.73+7.5% | 23.94+16.5% | 20.54-2.1% | 20.99 |
| EXPENSES | ||||||||
| Expenditure | 21.72+8.4% | 20.03+22.2% | 16.39-24.1% | 21.60-6.4% | 23.08+3.1% | 22.39+14.2% | 19.61-2.1% | 20.04 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 0.18 | — | — |
| PROFIT | ||||||||
| PBT | 1.42+130.9% | 0.61+102.9% | 0.30-86.5% | 2.24-15.6% | 2.65+71.3% | 1.55+65.2% | 0.94-2.0% | 0.96 |
| Net Profit | 1.42+130.9% | 0.61+102.9% | 0.30-86.5% | 2.24-15.6% | 2.65+93.2% | 1.37+46.5% | 0.94-2.0% | 0.96 |
| KEY METRICS | ||||||||
| OPM % | 8.11%+4.76pp | 3.35%-1.07pp | 4.42%-6.34pp | 10.76%-1.50pp | 12.26%+5.50pp | 6.76%+5.59pp | 1.17%+1.14pp | 0.03% |
| NPM % | 6.13%+3.15pp | 2.98%+1.17pp | 1.81%-7.57pp | 9.38%-0.92pp | 10.30%+4.57pp | 5.73%+1.17pp | 4.56%+0.01pp | 4.55% |
| EPS | 0.48+128.6% | 0.21+110.0% | 0.10-86.8% | 0.76-15.6% | 0.90+76.5% | 0.51+41.7% | 0.36+0.0% | 0.36 |
Corporate Events
Board Meeting
The Board of Directors approved the Scheme of Arrangement be…
BSE Filing ↗Board Meeting
The 24th Annual General Meeting of Brooks Laboratories Limit…
BSE Filing ↗Board Meeting
The Board of Directors meeting is scheduled to consider and …
BSE Filing ↗Board Meeting
The Board of Directors approved the sale of equity shares he…
BSE Filing ↗Board Meeting
The board meeting is scheduled to consider and approve the A…
BSE Filing ↗Board Meeting
Consideration, approval and taking on record of Audited Fina…
BSE Filing ↗Board Meeting
Consider and approve the Unaudited Standalone & Consolidated…
BSE Filing ↗Board Meeting
Consider and approve the Unaudited Standalone & Consolidated…
BSE Filing ↗Board Meeting
Consider and approve Audited Standalone and consolidated fin…
BSE Filing ↗Board Meeting
Consider and approve the unaudited standalone and consolidat…
BSE Filing ↗Board Meeting
consideration and approval of fund raising through Rights is…
BSE Filing ↗Board Meeting
consider and approve the unaudited standalone and consolidat…
BSE Filing ↗Board Meeting
approving unaudited financials for the 1st quarter ended 30t…
BSE Filing ↗